Surgical management of pulmonary aspergilloma. Role of single-stage cavernostomy with muscle transposition

Jpn J Thorac Cardiovasc Surg. 2000 Jan;48(1):56-9. doi: 10.1007/BF03218085.

Abstract

Objective: We reviewed the outcome of the patients with aspergilloma who were treated surgically.

Methods: Between July 1991 and October 1996, 11 patients with pulmonary aspergilloma underwent surgery. One underwent sequential bilateral tboracotomy and two underwent re-operation. The total number of operations was 14. Surgical procedures consisted of 5 cavernostomies with muscle transposition, 3 cavernostomies with muscle transposition and thoracoplasty, 1 lobectomy 1 pneumonectomy, 1 segmentectomy and 3 partial resections.

Results: Morbidity and mortality rates were 28.6% and 7.1%, respectively Two patients who underwent cavernostomy and muscle transposition experienced a relapse of aspergilloma 19 and 29 months after the operation, respectively, but both successfully underwent re-operation, including cavernostomy. Both are free of symptoms 28 and 30 months after re-operation, respectively. All survivors except for one who died of multiple organ failure remain free of symptoms 14 to 60 months after the most recent operation.

Conclusion: Our experience was not a controlled trial and two relapsed cases had undergone cavernostomy, our series may suggest that single-stage cavernostomy with muscle transposition is a viable surgical option for patients with pulmonary aspergilloma.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Aspergillosis / surgery*
  • Female
  • Humans
  • Lung Diseases, Fungal / surgery*
  • Male
  • Middle Aged
  • Muscles / transplantation*
  • Reoperation
  • Surgical Flaps
  • Thoracoplasty / methods
  • Thoracostomy / methods*
  • Treatment Outcome